Lu Yin
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Discovery of modifiable factors associated with Pan-Cancer Risk: An Exposome-Wide analysis.
Journal: Journal of advanced research
Published: October 22, 2025
Comprehensive Integrated Analysis Reveals the Spatiotemporal Microevolution of Cancer Cells in Patients with Bone-Metastatic Prostate Cancer.
Journal: Biomedicines
Published: March 06, 2025
PSMA-Targeted Nanoparticles with PI3K/mTOR Dual Inhibitor Downregulate P-Glycoprotein and Inactivate Myeloid-Derived Suppressor Cells for Enhanced Chemotherapy and Immunotherapy in Prostate Cancer.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: October 08, 2024
Preliminary clinical practice of radical prostatectomy without preoperative biopsy.
Journal: Chinese medical journal
Published: February 29, 2024
Integrative analysis identifies cancer cell-intrinsic RARRES1 as a predictor of prognosis and immune response in triple-negative breast cancer.
Journal: Frontiers in genetics
Published: December 23, 2023
Targeting DNA Damage and Repair Machinery via Delivering WEE1 Inhibitor and Platinum (IV) Prodrugs to Stimulate STING Pathway for Maximizing Chemo-Immunotherapy in Bladder Cancer.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: August 28, 2023
Cuproptosis Induced by ROS Responsive Nanoparticles with Elesclomol and Copper Combined with αPD-L1 for Enhanced Cancer Immunotherapy.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: December 29, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026